Publications by authors named "Zejia Yang"

Claim this Profile
E
Evaluation of co‑inhibition of ErbB family kinases and PI3K for HPV‑negative head and neck squamous cell carcinoma.
Xinyan Geng, Shirin Azarbarzin, Zejia Yang, Rena G Lapidus, Xiaoxuan Fan

Oncol Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential modulation of PI3K/Akt/mTOR activity by EGFR inhibitors: A rationale for co-targeting EGFR and PI3K in cisplatin-resistant HNSCC.
Jipei Liao, Zejia Yang, Shirin Azarbarzin, Kevin J Cullen, Hancai Dan

Head Neck· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatiotemporal Controllable Sono-Nanovaccines Driven by Free-Field Based Whole-Body Ultrasound for Personalized Cancer Therapy.
Yang Wang, Guangzhe Li, Jianlong Su, Yiming Liu, Xiaomai Zhang, Zejia Yang

Adv Sci (Weinh)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneously targeting ErbB family kinases and PI3K in HPV-positive head and neck squamous cell carcinoma.
Zejia Yang, Jipei Liao, Lisa Schumaker, Brandon Carter-Cooper, Rena G Lapidus

Oral Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Wee1 kinase to suppress proliferation and survival of cisplatin-resistant head and neck squamous cell carcinoma.
Zejia Yang, Jipei Liao, Rena G Lapidus, Xiaoxuan Fan, Ranee Mehra

Cancer Chemother Pharmacol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of IKKβ/NF-κB signaling pathway to improve Dasatinib efficacy in suppression of cisplatin-resistant head and neck squamous cell carcinoma.
Zejia Yang, Jipei Liao, Kevin J Cullen, Hancai Dan

Cell Death Discov· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of migration, invasion, and metastasis of cisplatin-resistant head and neck squamous cell carcinoma through IKKβ inhibition.
Jipei Liao, Zejia Yang, Brandon Carter-Cooper, Elizabeth T Chang, Eun Yong Choi

Clin Exp Metastasis· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of cisplatin-resistant head and neck squamous cell carcinoma by combination of Afatinib with PD0325901, a MEK inhibitor.
Xiaofeng Lin, Jipei Liao, Zejia Yang, Xiaoxuan Fan, Kevin J Cullen

Am J Cancer Res· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway.
Zejia Yang, Jipei Liao, Brandon A Carter-Cooper, Rena G Lapidus, Kevin J Cullen

BMC Cancer· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer.
Zhipeng Li, Jipei Liao, Zejia Yang, Eun Yong Choi, Rena G Lapidus

Br J Cancer· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-kB regulates head and neck squamous cell carcinoma proliferation.
Zhipeng Li, Zejia Yang, Antonino Passaniti, Rena G Lapidus, Xuefeng Liu

Oncotarget· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IKK phosphorylation of NF-κB at serine 536 contributes to acquired cisplatin resistance in head and neck squamous cell cancer.
Zhipeng Li, Zejia Yang, Rena G Lapidus, Xuefeng Liu, Kevin J Cullen

Am J Cancer Res· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer.
Kevin J Cullen, Zejia Yang, Lisa Schumaker, Zhongmin Guo

J Bioenerg Biomembr· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cisplatin preferentially binds mitochondrial DNA and voltage-dependent anion channel protein in the mitochondrial membrane of head and neck squamous cell carcinoma: possible role in apoptosis.
Zejia Yang, Lisa M Schumaker, Merrill J Egorin, Eleanor G Zuhowski, Zhongmin Guo

Clin Cancer Res· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance.
Charles M Rudin, Zejia Yang, Lisa M Schumaker, David J VanderWeele, Kenneth Newkirk

Cancer Res· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis